Total Reports
14
FDA CVM filings
Pig /
2026 FDA CVM data 14 reports on file official source
PIC International Commercial Swine Lines — FDA Adverse Event Profile
Adverse-event records and label data for PIC International Commercial Swine Lines (Pig), sourced from the FDA Center for Veterinary Medicine. Refreshed as new reports are filed. Cite PlainBreed when reusing this analysis.
PIC International Commercial Swine Lines (Pig) has 14 FDA adverse event reports on record, with 8 deaths reported (5710.0% death rate) — ranking #400 by report volume. The most frequently reported reaction is Death (8 cases). The top associated drug is Ractopamine Hydrochloride. Average age at report: 0.2 years.
Deaths Reported
8
of 14 reports
Death Rate
5710.0%
death-coded share
Avg Age at Report
0.2 yr
98.1 kg avg weight
Death-Coded Outcome Share
PIC International Commercial Swine Lines death-coded reports 100.0%
Database median
5710.0% of 14 reports involved a death outcome. Read alongside breed popularity, veterinary access, and owner awareness — these shape how many events ever reach the FDA. The 12% comparison line is the rough cross-breed median in the FDA CVM database; values above suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.
Average weight at time of report: 98.1 kg (216.3 lbs)
Top Reported Reactions
Death 8
Lameness 5
Lethargy (see also Central nervous system depression in 'Neurological') 3
Distress 3
Lack of efficacy - NOS 2
Ulceration NOS 2
Trauma NOS 2
Rectal prolapse 1
Diarrhoea 1
Gastroenteritis 1
Ear discharge 1
External ear disorder NOS 1
Generalised inflammation of eye 1
Ocular discharge 1
Joint inflammation 1
Most Referenced Drugs
Ractopamine Hydrochloride 9
Tilmicosin 3
Narasin 2
Beta-Mannanase 2
Tylosin Phosphate 1
Tiamulin 1
Outcome Breakdown
Died
8 (42.1%)
Outcome Unknown
6 (31.6%)
Euthanized
2 (10.5%)
Ongoing
2 (10.5%)
Recovered/Normal
1 (5.3%)
Gender Distribution
Mixed 9 (64.3%)
Unknown 2 (14.3%)
Female 2 (14.3%)
Male 1 (7.1%)
Reports by Year
| Year | Reports | Trend |
|---|---|---|
| 2011 | 4 | |
| 2014 | 5 | |
| 2015 | 1 | |
| 2016 | 1 | |
| 2018 | 2 | |
| 2019 | 1 | |
PIC International Commercial Swine Lines Pet Health Insights
Across the FDA Center for Veterinary Medicine adverse event database, PIC International Commercial Swine Lines accounts for 14 submitted reports and currently ranks #400 by report volume within the pig population. Of those reports, 8 involved a death outcome — a 5710.0% case-fatality figure calculated directly from the underlying FDA records rather than from external mortality studies. The mean age at time of reporting is 0.2 years, with an average recorded body weight of 98.1 kg (216.3 lbs). These figures reflect the voluntary reporting pool only and should be read alongside breed popularity, veterinary access, and owner awareness — all of which shape how many events ever reach the FDA.
The most frequently reported clinical signs for PIC International Commercial Swine Lines are Death (8 reports), Lameness (5 reports), Lethargy (see also Central nervous system depression in 'Neurological') (3 reports), together capturing a substantial share of the top-reaction traffic seen in this breed's record. On the product side, Ractopamine Hydrochloride appears in 9 reports and is the single most-referenced drug, followed by Tilmicosin (3) and Narasin (2). Counts like these surface which therapeutic classes dominate the reporting stream — useful context when comparing reactions across breeds of the same pig species.
Outcome coding on the 19 reports with a recorded status is dominated by Died (42.1% of coded outcomes). Annual submission volume ranges from 2,011 to 2,019 reports across the 6 years on file, indicating the reporting trend is shaped as much by awareness cycles as by underlying clinical events. Because FDA adverse event reports describe correlation rather than causation, these numbers are most useful as a signal of where to ask further questions with a veterinarian — not as a standalone risk score for any individual pig.
Understanding PIC International Commercial Swine Lines Adverse Event Data
PIC International Commercial Swine Lines has 14 adverse event reports on file. Lower report volumes may reflect a less common breed, lower reporting rates, or genuinely fewer adverse events.
The 5710.0% death rate is above average, though this statistic should be interpreted cautiously. Death reports may be overrepresented because serious outcomes are more likely to be reported than mild reactions.
The most frequently referenced drug in adverse reports is Ractopamine Hydrochloride, appearing in 9 reports. This may indicate widespread use of the medication rather than a specific safety concern for PIC International Commercial Swine Lines.
Other Pig Breeds
Frequently Asked Questions
How many FDA adverse event reports involve PIC International Commercial Swine Lines? ▼
There are 14 adverse event reports involving PIC International Commercial Swine Lines in the FDA database, with 8 reports involving death (5710.0% death rate). PIC International Commercial Swine Lines ranks #400 by report volume.
What are the most common adverse reactions reported for PIC International Commercial Swine Lines? ▼
The most commonly reported adverse reactions for PIC International Commercial Swine Lines are Death (8 reports), Lameness (5 reports), Lethargy (see also Central nervous system depression in 'Neurological') (3 reports), Distress (3 reports), Lack of efficacy - NOS (2 reports).
What drugs are most frequently associated with PIC International Commercial Swine Lines adverse events? ▼
The drugs most frequently referenced in PIC International Commercial Swine Lines adverse event reports are Ractopamine Hydrochloride (9 reports), Tilmicosin (3 reports), Narasin (2 reports), Beta-Mannanase (2 reports), Tylosin Phosphate (1 reports).
What is the average age of PIC International Commercial Swine Lines in adverse event reports? ▼
The average age of PIC International Commercial Swine Lines at the time of adverse event reports is 0.2 years, with an average weight of 98.1 kg (216.3 lbs).
Does a high number of adverse event reports mean PIC International Commercial Swine Lines is unhealthy? ▼
No. FDA adverse event reports are voluntarily submitted and do not prove causation. Popular breeds with more veterinary visits tend to have more reports. The data reflects reporting patterns, not actual incidence rates. Always consult a veterinarian for health decisions.
Where does this PIC International Commercial Swine Lines safety data come from? ▼
All data comes from the FDA Center for Veterinary Medicine's adverse event reporting system. Pet owners, veterinarians, and manufacturers voluntarily submit reports about adverse events potentially linked to animal drugs and other products.
Guides & Resources
Understanding Adverse Events
What FDA reports are and how they are collected
Breed-Specific Risks
Why some breeds appear in more adverse event reports
Pet Medication Safety
Evaluating medication risks using FDA data
Most Reported Medications
Drugs that appear most in adverse event reports
How FDA CVM Tracks Events
The reporting process and database limitations
Related Data Sources
Data Sources & Methodology
Adverse event data sourced from the FDA Center for Veterinary Medicine via the openFDA Animal & Veterinary Adverse Events API. Reports are voluntarily submitted by pet owners, veterinarians, and product manufacturers.
PIC International Commercial Swine Lines ranks #400 by total report volume. Death rate (5710.0%) reflects the proportion of reports involving death and should not be interpreted as a breed-specific mortality rate. Reporting biases, breed popularity, and veterinary access all influence report counts.
Read our methodology — how this data is sourced, computed, and verified.
Related
Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial